Protein tyrosine phosphatase receptor type Z1 inhibits the cisplatin resistance of ovarian cancer by regulating PI3K/AKT/mTOR signal pathway

Most patients with ovarian cancer (OC) get remission after undergoing cytoreductive surgery and platinum-based standard chemotherapy, but more than 50% of patients with advanced OC relapse within the first 5 years after treatment and develop resistance to standard chemotherapy. The production of med...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peng, Hu, Yuanjing, Qu, Pengpeng, Zhao, Ying, Liu, Jing, Zhao, Jianguo, Kong, Beihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805848/
https://www.ncbi.nlm.nih.gov/pubmed/35001804
http://dx.doi.org/10.1080/21655979.2021.2022268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805848/
https://www.ncbi.nlm.nih.gov/pubmed/35001804
http://dx.doi.org/10.1080/21655979.2021.2022268

Ejemplares similares